Integration of estrogen and progesterone receptors with pathological and molecular prognostic factors in breast cancer patients (original) (raw)
Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma
Graham Colditz
Cancer, 2004
View PDFchevron_right
Association of Hormone-Related Characteristics and Breast Cancer Risk by Estrogen Receptor/Progesterone Receptor Status in the Shanghai Breast Cancer Study
Yu-Tang Gao
American Journal of Epidemiology, 2011
View PDFchevron_right
American Society of Clinical Oncology/College ofAmerican Pathologists guideline recommendations forimmunohistochemical testing of estrogen andprogesterone receptors in breast cancer
Lisa McShane
Archives of Pathology & Laboratory Medicine, 2010
View PDFchevron_right
Estrogen and progesterone receptor mrna levels in primary breast cancer: Association with patient survival and other clinical and tumor features
Maria Nagai
International Journal of Cancer, 1994
View PDFchevron_right
Physiological and Pathological Roles of Estrogen Receptor
Kenneth Korach
Estrogen Receptor and Breast Cancer, 2018
View PDFchevron_right
The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
Geraldine Laven-Law
Nature Medicine, 2021
View PDFchevron_right
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women's Health Initiative Observational Study
Jean Wactawski-wende
Breast Diseases: A Year Book Quarterly, 2013
View PDFchevron_right
Estrogen Plus Progestin Therapy and Breast Cancer in Recently Postmenopausal Women
Garnet Anderson
American Journal of Epidemiology, 2008
View PDFchevron_right
Predicting Risk of Breast Cancer in Postmenopausal Women by Hormone Receptor Status
Garnet Anderson
JNCI Journal of the National Cancer Institute, 2007
View PDFchevron_right
Decreased Androgen Receptor Levels and Receptor Function in Breast Cancer Contribute to the Failure of Response to Medroxyprogesterone Acetate
Carmela Ricciardelli
Cancer Research, 2005
View PDFchevron_right
Effect of level of hormone-receptor expression on treatment outcomes of “triple-positive” early-stage breast cancer
Rawan Mustafa
Breast Cancer Research and Treatment, 2020
View PDFchevron_right
Elucidating the role of androgen receptor in breast cancer
Aditi H
Clinical Investigation, 2012
View PDFchevron_right
Estrogen Induces Repression of the Breast Cancer and Salivary Gland Expression Gene in an Estrogen Receptor Dependent Manner
Nicola Miller
Cancer Research, 2008
View PDFchevron_right
Data from ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer
Olle Stål
2023
View PDFchevron_right
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines
Francesca De Amicis
Breast Cancer Research, 2014
View PDFchevron_right
Reproductive Steroid Hormones and Recurrence-Free Survival in Women with a History of Breast Cancer
Frank Stanczyk
Cancer Epidemiology Biomarkers & Prevention, 2008
View PDFchevron_right
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
Garnet Anderson
Breast Cancer Research, 2018
View PDFchevron_right
Estrogen receptors in 699 primary breast cancers: A comparison of immunohistochemical and biochemical methods
Gianluigi Cetto
Breast Cancer Research and Treatment, 1995
View PDFchevron_right
Regulation of estrogen receptor concentration and activity by an erbB/HER ligand in breast carcinoma cell lines
Marc Lippman
Endocrinology, 1996
View PDFchevron_right
What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer?
Ricardo Caponero
Annals of Oncology, 2009
View PDFchevron_right
Risk of second breast cancer according to estrogen receptor status and family history
Monica Castiglione
Breast Cancer Research and Treatment, 2011
View PDFchevron_right
How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer
Teri Oldaker
Cancer, 1993
View PDFchevron_right
Different associations of estrogen receptor β isoforms, ERβ1 and ERβ2, expression levels with tumor size and survival in early- and late-onset breast cancer
Ksenija Kanjer
Cancer Letters, 2012
View PDFchevron_right
Assessment of 25-Year Survival of Women With Estrogen Receptor–Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy
Olle Stål
JAMA network open, 2021
View PDFchevron_right
Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer
Saudade Andre
SpringerPlus, 2013
View PDFchevron_right
Breast Cancer Risk and the Combined Effect of Environmental Estrogens
Nicolas Olea
Cancer Causes & Control, 2004
View PDFchevron_right
Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial
Kirsten Nielsen
European Journal of Cancer, 2014
View PDFchevron_right
Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo
Hareesh Nair
PLOS ONE, 2016
View PDFchevron_right
Difference in hormone receptor content in breast cancers from Vietnamese and Swedish women
Thanh Niall
Acta oncologica (Stockholm, Sweden)
View PDFchevron_right
Importance of Breast Cancer Subtype in the Development of Androgen-Receptor-Directed Therapy
Aditi H
Current Breast Cancer Reports, 2014
View PDFchevron_right
Clinical Studies on Hormonal Status in Breast Cancer and its Impact on Quality of Life(QOL)
Kaiser Jamil
Journal of Cancer Science & Therapy, 2009
View PDFchevron_right
Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages — Immunohistochemical study of 107 cases
Eliezer Shalev
Breast Cancer Research and Treatment, 1990
View PDFchevron_right
9q31. 2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
E. Khusnutdinova
2012
View PDFchevron_right
Exploring estrogenic activity in lung cancer
Margarita Lianeri
Molecular Biology Reports, 2016
View PDFchevron_right
Clinical and molecular aspects of breast cancer: Targets and therapies
Glauber Leitao
Biomedicine & Pharmacotherapy, 2018
View PDFchevron_right